Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Robocath Achieves Positive Results in R-Evolution Multicenter European Clinical Study on Robotic Coronary Angioplasty
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of […]
Robocath Concludes First European Clinical Study to Demonstrate Safety and Efficacy of Robotic Coronary Angioplasty Performed with R-One
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of […]
Robocath Successfully Performs First Carotid Stenting in France with R-One™ Robot at Rennes University Hospital
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of […]
Robocath and Rennes University Hospital Launch Co-development Research Program into Treatment of Strokes in Partnership with Philips France
Robocath, a company that designs, develops and commercializes robotic solutions to treat cardiovascular diseases, and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more